secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001641172-25-022575
Event type: debt
Sentiment:  negative
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma issues $100K convertible note to Labrys Fund at 60% discount conversion
--------------------------------------------------------------------------------

- Principal $100,000; net proceeds $85,000 after $15,000 original issue discount.
- 6% interest per annum; maturity date August 5, 2026.
- Conversion price is 60% of lowest trading price over prior 20 trading days.
- Beneficial ownership limitation set at 4.99% (can be increased to 9.99% by holder).
- Shares upon conversion are unregistered and subject to restrictive legend.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000164117225022575/0001641172-25-022575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000164117225022575/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer